Eculizumab in Paroxysmal Nocturnal Hemoglobinuria With Budd-Chiari Syndrome Progressing Despite Anticoagulation

Experimental Hematology and Oncology - United Kingdom
doi 10.1186/2162-3619-1-26
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Pathophysiology of Paroxysmal Nocturnal Hemoglobinuria and Treatment With Eculizumab

Therapeutics and Clinical Risk Management
2009English

Effects of Immunosuppressive Therapy in a Patient With Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria (AA-PNH) Syndrome During Ongoing Eculizumab Treatment

Internal Medicine
Internal MedicineMedicine
2014English

Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria

American Journal of Hematology
Hematology
2016English

Improvement of Renal Function by Long-Term Sustained Eculizumab Treatment in a Patient With Paroxysmal Nocturnal Hemoglobinuria

Case Reports in Hematology
2015English

Budd-Chiari Syndrome

Archives of the Balkan Medical Union
Medicine
2019English

Acute Myeloblastic Leukemia in Paroxysmal Nocturnal Hemoglobinuria. Evidence of Evolution From the Abnormal Paroxysmal Nocturnal Hemoglobinuria Clone.

Journal of Clinical Investigation
Medicine
1987English

Effectiveness of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) With or Without Aplastic Anemia in the International PNH Registry

American Journal of Hematology
Hematology
2018English

Budd Chiari Syndrome With Hepato Hydrothorax

Medical Journal Armed Forces India
Medicine
1999English

Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed

Indian Journal of Hematology and Blood Transfusion
Hematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy